Find the Perfect Plan for Your Investment Journey
O
Latest price
52 Week Range
€3.50 - €7.24
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | €179.47M |
EV | €164.74M |
Shares Outstanding | 44.65M |
Beta | 0.87 |
Analyst Rating | BUY |
Analyst Target Price | €15.15 |
P/E 2025E | - |
P/Revenue 2025E | 22.74x |
Revenue | 6.70% |
EPS | - |
Operating Cash Flow | -16.00% |
Free Cash Flow | - |
Revenue | 247.40% |
EPS | - |
Operating Cash Flow | 18.60% |
Free Cash Flow | - |
Gross Margin 2025E | 70.00% |
Net Profit Margin 2025E | -628.67% |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
O
Onward Medical N.V.
ONWD
Sector
Healthcare
Industry
Biotechnology
CEO
Marver, David
Employees
99
Website
www.onwd.comIPO Date
2021-10-21
Headquarters
Schimmelt 2, Eindhoven, Noord-Brabant, NL-5656, Netherlands
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved